+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CONCORD CONCORD

Concord Drugs Share Price

₹76.74 +0.91 (1.2%)
25.80% Gain from 52W Low

25 Sep, 2026 4:01 PM (IST)

Concord Drugs live price: ₹76.74. It opened at ₹82 vs previous close ₹76; intraday high/low: ₹82/₹76. The 50 & 200 DMA stand at ₹76.60/₹74.30.

Concord Drugs Performance

  • Today's Low
  • ₹76
  • Today's High
  • ₹82
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹93
  • Open Price₹82
  • Previous Close₹76
  • Volume5,928
  • 50 DMA₹76.60
  • 100 DMA₹76.40
  • 200 DMA₹74.30

Concord Drugs Chart

Investment Returns

  • Over 1 Month -2.9%
  • Over 3 Month + 0.54%
  • Over 6 Month + 7.18%
  • Over 1 Year + 16.27%

Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!

Invest Now

Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 49.3
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 101
  • P/B Ratio
  • 2
  • Average True Range
  • 4.7
  • EPS
  • 1.6
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.2
  • RSI
  • 52.41
  • MFI
  • 28.9

Latest Stock News Updates

Concord Drugs Ltd - 538965 - Closure of Trading Window

Closure of trading Window

Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Copies of News paper publications of the Notice of the 31st AGM to be held on 30.09.2026

Concord Drugs Ltd - 538965 - Letter To Shareholders

Letter to members as per regulation 36(1)(b)

Concord Drugs Financials

Concord Drugs Technicals

EMA & SMA

Current Price
₹76.74
+ 0.91 (1.2%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹77.50
  • 50 Day
  • ₹76.60
  • 100 Day
  • ₹76.40
  • 200 Day
  • ₹74.30

Resistance and Support

78.25 Pivot Speed
  • R3 87.50
  • R2 84.80
  • R1 81.50
  • S1 75.60
  • S2 72.80
  • S3 69.60

Concord Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-10 Quarterly Results
2026-05-27 Audited Results
2026-02-14 Quarterly Results
2025-11-13 Quarterly Results
2025-08-08 Quarterly Results

Concord Drugs Shareholding Pattern

54.91%
45.08%
0%

Concord Drugs FAQs

Concord Drugs share price is ₹76 As on 26 September, 2026 | 19:01

The Market Cap of Concord Drugs is ₹101.1 Cr As on 26 September, 2026 | 19:01

The P/E ratio of Concord Drugs is 49.3 As on 26 September, 2026 | 19:01

The PB ratio of Concord Drugs is 2 As on 26 September, 2026 | 19:01

The 52 week High & Low of Concord Drugs is ₹92.5/₹61 respectively As on 26 September, 2026 | 19:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23